Physician profile
Kevin A Copeland
NPI 1265563571
$1,733.05
in general payments reported to CMS, 2019-2025
19 companies · $210 in 2025
The $210 reported for 2025 was more than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $422 · 2020: $162 · 2021: $573 · 2022: $19.79 · 2023: $209 · 2024: $137 · 2025: $210.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $556.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $556.09 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $638.95 | 2021-2025 | Corevalve Evolut R |
| Boston Scientific Corporation | $194.51 | 2019-2020 | |
| Astrazeneca Pharmaceuticals LP | $154.50 | 2019-2025 | |
| Akcea Therapeutics, INC. | $129.89 | 2019 | |
| Sanofi-Aventis U.S. LLC | $117.15 | 2021 | |
| Janssen Scientific Affairs, LLC | $78.80 | 2024 | Xarelto |
| Chiesi USA, INC. | $64.59 | 2019 | |
| Cardiovascular Systems INC. | $61.75 | 2023 | Diamondback Coronary |
| Abiomed | $53.76 | 2023-2024 | Impella |
| Amgen INC. | $50.02 | 2019 | |
| Novartis Pharmaceuticals Corporation | $30.56 | 2019-2021 | |
| Amarin Pharma, INC. | $29.65 | 2019 | |
| Medtronic Vascular, INC. | $28.66 | 2019 | |
| Kestra Medical Technology Services, INC. | $24.52 | 2025 | Assure Wcd |
| E.R. Squibb & Sons, L.L.C. | $19.79 | 2022 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kiniksa Pharmaceuticals International, Plc | $17.70 | 2024 | Arcalyst |
| Arbor Pharmaceuticals, INC. | $14.20 | 2019 | |
| Janssen Pharmaceuticals, INC | $12.22 | 2019 | |
| Pfizer INC. | $11.83 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kevin Copeland listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.